NCT05050617

Brief Summary

This study is an observational, prospective study examining the role point-of-care echocardiography of predicting short term adverse outcomes in emergency department patients with acute pulmonary embolism. The primary objective is to assess the diagnostic performance of ultrasound-guided measures of right ventricular dilation (RVD) and strain in predicting clinical outcomes in acute PE. The secondary objective is to investigate the utility of combining ultrasound-guided measures of RVD and the pulmonary embolism severity index (PESI) score in predicting adverse outcomes in acute PE.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
6mo left

Started Sep 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Sep 2021Dec 2026

First Submitted

Initial submission to the registry

August 31, 2021

Completed
9 days until next milestone

Study Start

First participant enrolled

September 9, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 20, 2021

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

June 3, 2026

Status Verified

June 1, 2026

Enrollment Period

5 years

First QC Date

August 31, 2021

Last Update Submit

June 2, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Adverse Events at 5 days

    Composite of recurrent/worsening VTE (including PE or DVT), new cardiac dysrhythmia, major bleeding, return to the ED, death or need for critical interventions (including advanced cardiac life support, advanced respiratory support, vasopressor support, thrombolysis or new oxygen requirement occurring after initial presentation) occurring within 5 days of acute PE diagnosis

    Within 5 days of presentation/enrollment

Secondary Outcomes (3)

  • Adverse Events during Index Hospitalization

    Between time of presentation/enrollment and discharge from index hospitalization

  • Adverse Events within 14 days

    Within 14 days of presentation/enrollment

  • Adverse Events within 30 days

    Within 30 days of presentation/enrollment

Study Arms (1)

Acute Pulmonary Embolism

Subjects in this single cohort will undergo point-of-care echocardiography at the time of presentation and subsequent follow up to assess for short term adverse events or complications.

Diagnostic Test: Point-of-care echocardiography

Interventions

Subjects will undergo point-of-care echocardiography at the time of presentation/enrollment to assess for evidence of right sided heart dilation/strain.

Acute Pulmonary Embolism

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of ED patients over the age of 18 who have an acute pulmonary embolism identified on CT imaging.

You may qualify if:

  • Age \>= 18 years of age
  • ED diagnosis of acute pulmonary embolism with identification on CT imaging

You may not qualify if:

  • Age \<18 years of age
  • Inability to provide informed consent
  • Incarceration
  • Current PE previously diagnosed prior to index ED visit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wellspan York Hospital

York, Pennsylvania, 17403, United States

RECRUITING

Related Publications (11)

  • Alerhand S, Hickey SM. Tricuspid Annular Plane Systolic Excursion (TAPSE) for Risk Stratification and Prognostication of Patients with Pulmonary Embolism. J Emerg Med. 2020 Mar;58(3):449-456. doi: 10.1016/j.jemermed.2019.09.017. Epub 2019 Nov 15.

    PMID: 31735658BACKGROUND
  • Aujesky D, Perrier A, Roy PM, Stone RA, Cornuz J, Meyer G, Obrosky DS, Fine MJ. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med. 2007 Jun;261(6):597-604. doi: 10.1111/j.1365-2796.2007.01785.x.

    PMID: 17547715BACKGROUND
  • Carley S, Dosman S, Jones SR, Harrison M. Simple nomograms to calculate sample size in diagnostic studies. Emerg Med J. 2005 Mar;22(3):180-1. doi: 10.1136/emj.2003.011148.

    PMID: 15735264BACKGROUND
  • Chan CM, Woods C, Shorr AF. The validation and reproducibility of the pulmonary embolism severity index. J Thromb Haemost. 2010 Jul;8(7):1509-14. doi: 10.1111/j.1538-7836.2010.03888.x. Epub 2010 Apr 16.

    PMID: 20403093BACKGROUND
  • Ciurzynski M, Kurnicka K, Lichodziejewska B, Kozlowska M, Plywaczewska M, Sobieraj P, Dzikowska-Diduch O, Goliszek S, Bienias P, Kostrubiec M, Pruszczyk P. Tricuspid Regurgitation Peak Gradient (TRPG)/Tricuspid Annulus Plane Systolic Excursion (TAPSE) - A Novel Parameter for Stepwise Echocardiographic Risk Stratification in Normotensive Patients With Acute Pulmonary Embolism. Circ J. 2018 Mar 23;82(4):1179-1185. doi: 10.1253/circj.CJ-17-0940. Epub 2018 Jan 26.

    PMID: 29375106BACKGROUND
  • Daley J, Grotberg J, Pare J, Medoro A, Liu R, Hall MK, Taylor A, Moore CL. Emergency physician performed tricuspid annular plane systolic excursion in the evaluation of suspected pulmonary embolism. Am J Emerg Med. 2017 Jan;35(1):106-111. doi: 10.1016/j.ajem.2016.10.018. Epub 2016 Oct 11.

    PMID: 27793505BACKGROUND
  • Donze J, Le Gal G, Fine MJ, Roy PM, Sanchez O, Verschuren F, Cornuz J, Meyer G, Perrier A, Righini M, Aujesky D. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost. 2008 Nov;100(5):943-8. doi: 10.1160/th08-05-0285.

    PMID: 18989542BACKGROUND
  • Hariharan P, Takayesu JK, Kabrhel C. Association between the Pulmonary Embolism Severity Index (PESI) and short-term clinical deterioration. Thromb Haemost. 2011 Apr;105(4):706-11. doi: 10.1160/TH10-09-0577. Epub 2011 Jan 12.

    PMID: 21225095BACKGROUND
  • Kurzyna M, Torbicki A, Pruszczyk P, Burakowska B, Fijalkowska A, Kober J, Oniszh K, Kuca P, Tomkowski W, Burakowski J, Wawrzynska L. Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism. Am J Cardiol. 2002 Sep 1;90(5):507-11. doi: 10.1016/s0002-9149(02)02523-7.

    PMID: 12208411BACKGROUND
  • Rydman R, Soderberg M, Larsen F, Alam M, Caidahl K. d-Dimer and simplified pulmonary embolism severity index in relation to right ventricular function. Am J Emerg Med. 2013 Mar;31(3):482-6. doi: 10.1016/j.ajem.2012.09.016. Epub 2012 Nov 12.

    PMID: 23154103BACKGROUND
  • Shafiq Q, Moukarbel GV, Gupta R, Hernandez DA, Khouri SJ. Practical echocardiographic approach for risk stratification of patients with acute pulmonary embolism. J Echocardiogr. 2016 Dec;14(4):146-155. doi: 10.1007/s12574-016-0306-4. Epub 2016 Aug 10.

    PMID: 27510333BACKGROUND

MeSH Terms

Conditions

Pulmonary Embolism

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesEmbolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Brent A Becker, MD

    WellSpan Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Brent A Becker, MD

CONTACT

Kristen Oliff, BS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Director, Department of Emergency Medicine

Study Record Dates

First Submitted

August 31, 2021

First Posted

September 20, 2021

Study Start

September 9, 2021

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

June 3, 2026

Record last verified: 2026-06

Locations